Skip to content

Magnetic Resonance Imaging of Brain Development in Autism

Magnetic Resonance Imaging of Brain Development in Autism

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00449566
Enrollment
300
Registered
2007-03-20
Start date
2006-01-31
Completion date
Unknown
Last updated
2007-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism

Keywords

Magnetic Resonance Imaging, Diffusion Tensor Imaging

Brief summary

The purpose of this study is to investigate brain development in autism by longitudinally assessing children with autism, as well as typically developing controls, using advanced MR techniques. We will use longitudinal diffusion tensor imaging (DTI) measures to investigate the protracted development of long-range white matter fibers in autism. In addition, we will investigate the effect of autism risk genes on brain development.

Interventions

None listed

Sponsors

UMC Utrecht
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
6 Years to 18 Years
Healthy volunteers
Yes

Inclusion criteria

1. Aged 6 - 18 years at initial MRI Inclusion criteria for subjects with autism 1\) DSM-IV (APA, 1994) diagnosis of autism, according to ADI-R interview Inclusion criteria for controls 1. no DSM-IV (APA, 1994) diagnosis, according to DISC interview 2. no scores in the clinical range on the Child Behavior Checklist (CBCL) and Teacher Rating Form (TRF) 3. IQ \> 70

Exclusion criteria

1. major illness of the cardiovascular, the endocrine, the pulmonal or the gastrointestinal system 2. presence of metal objects in or around the body (pacemaker, dental braces) 3. history of or present neurological disorder 4. for individuals over 12 years of age: legal incompetence, defined as the obvious inability to comprehend the information that is presented by the investigator and is outlined in the Information letter and on which the decision to participate in the study is to be based

Countries

Netherlands

Contacts

Primary ContactSarah Durston
S.Durston@umcutrecht.nl+31 30 250 8161

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026